EPISODE · Aug 13, 2025 · 11 MIN
Targeted Therapy for Pancreatic Cancer: Personalized Treatment That Improves Outcomes and Comfort
In this episode, we dive into how targeted therapy is changing the way doctors treat pancreatic cancer, offering hope and a better quality of life for patients facing this challenging disease.You’ll learn:What targeted therapy is and how it differs from chemotherapyHow gene mutations like BRCA1, BRCA2, and NTRK fusion influence treatmentWhy targeted therapy is beneficial for advanced or metastatic cancerHow does this approach protect healthy cells and reduce side effectsWho qualifies for targeted therapy based on tumor testingHow personalized care plans lead to more effective and comfortable treatmentThe role of clinical trials in providing access to the latest therapiesWhether you or a loved one is dealing with pancreatic cancer, this episode shows how precision medicine is creating more innovative, safer ways to fight back.Blog Link: Targeted Therapy for Pancreatic CancerSend us Fan MailThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.Author: Dr. CHRISTINA NG VAN TZE📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
What this episode covers
In this episode, we dive into how targeted therapy is changing the way doctors treat pancreatic cancer, offering hope and a better quality of life for patients facing this challenging disease. You’ll learn: What targeted therapy is and how it differs from chemotherapyHow gene mutations like BRCA1, BRCA2, and NTRK fusion influence treatmentWhy targeted therapy is beneficial for advanced or metastatic cancerHow does this approach protect healthy cells and reduce side effectsWho qualifies for ta...
NOW PLAYING
Targeted Therapy for Pancreatic Cancer: Personalized Treatment That Improves Outcomes and Comfort
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m